Diabetes & Peripheral Arterial Disease
The TruPAD™ is an FDA Cleared Device that Measures Peripheral Arterial Disease (PAD) at the Point-of-Care. PAD is a condition where the arteries that serve the extremities narrow, reducing blood flow. Over time, this can result in health issues such as heart failure, diabetes, and renal failure, all of which can lead to death depending on the patient's condition. Risk factors for PAD are smoking, diabetes, high blood cholesterol, high blood pressure, heart disease, and stroke.
TruPAD™ measures the blood pressure in the lower-extremities with or without exercise (computer included).
Peripheral Arterial Disease (PAD) is a condition that reduces blood flow to the legs and feet. This can cause pain and tissue damage, especially in people with diabetes and a history of smoking. Research suggests that one in five elderly people suffer from hardened arteries that reduce blood flow to the limbs. The TruPAD™ is an innovative solution that can diagnose PAD quickly and accurately in your office without requiring Doppler or vascular expertise. Results and reports are generated in seconds with minimal training.
Early detection and treatment of Peripheral Artery Disease (PAD) can save lives and improve patient health. TruPAD™ is ideal for calcified or incompressible arteries and diabetic patients and less sensitive to operator error. Over half of PAD patients are asymptomatic or misdiagnosed, making testing essential. Validate patient trust and potentially receive a great return on investment with reimbursable PAD tests.
Get the TruPAD™ to diagnose PAD and improve patients' quality of life in less than 5-minutes. The non-invasive device includes a computer with software, PVR, 2x10cm cuffs, an inflation bulb, a carry bag, a user manual, and quick reference guides.